Axillary lymph node dissection in early-stage invasive breast cancer: Is it still standard today?

Breast Cancer Research and Treatment

Volumn 128, Issue 3, 2011, Pages 613-624

  Gerber, Bernd ^a   Heintze, Kristin ^a   Stubert, Johannes ^a   Dieterich, Max ^a   Hartmann, Steffi ^a   Stachs, Angrit ^a   Reimer, Toralf ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Axillary lymph nodes; Breast cancer; Dissection; Metastases; Prognosis; Sentinel

Indexed keywords

ANTINEOPLASTIC AGENT;

ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; EARLY CANCER; ECHOMAMMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 79960839970     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1532-0     Document Type: Review

References (130)

1. GF Schwartz AE Guiliano U Veronesi 2002 Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA Breast J 8 124 138 12078657
2. GH Lyman AE Giuliano MR Somerfield, et al. 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703 7720 16157938 (Pubitemid 46291835)
3. DN Krag SJ Anderson TB Julian, et al. 2010 Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 927 933 20863759
4. R Crane-Okada RA Wascher D Elashoff, et al. 2008 Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer Ann Surg Oncol 15 1996 2005 18415650
5. AGO (2011) Diagnostic and treatment of early and metastatic breast cancer. http://www.ago-online.org
6. NCCN (National Comprehensive Cancer Network) (2011). NCCN practice guidelines in oncology: breast cancer. Version 02.2011. http://www.nccn.org
7. Cochrane Collaboration (2010) http://www.cochrane.org
8. C Lanng J Hoffmann H Galatius, et al. 2007 Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer Eur J Surg Oncol 33 281 284 17084579 1:STN:280:DC%2BD2s7pvV2htw%3D%3D (Pubitemid 46488662)
9. MC Specht JV Fey PI Borgen, et al. 2005 Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200 10 14 15631914 (Pubitemid 41583109)
10. IM Mathijssen H Strijdhorst SK Kiestra, et al. 2006 Added value of ultrasound in screening the clinically negative axilla in breast cancer J Surg Oncol 94 364 367 16967456 1:STN:280:DC%2BD28rlsVyhug%3D%3D (Pubitemid 44465338)
11. J Zgajnar M Hocevar M Podkrajsek, et al. 2006 Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients Breast Cancer Res Treat 97 293 299 16333526 (Pubitemid 43945759)
12. JC Boughey JP Moriarty AC Degnim, et al. 2010 Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer Ann Surg Oncol 17 953 958 20127185
13. SH Park MJ Kim BW Park, et al. 2011 Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer Ann Surg Oncol 18 738 744 20890729
14. BP Baruah A Goyal P Young, et al. 2010 Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer Br J Surg 97 680 683 20186888 1:STN:280:DC%2BC3c3mt1eiug%3D%3D
15. S Alvarez E Anorbe P Alcorta, et al. 2006 Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review AJR Am J Roentgenol 186 1342 1348 16632729 (Pubitemid 46112571)
16. A Garcia Fernandez M Fraile N Gimenez, et al. 2011 Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy Ultrasound Med Biol 37 16 22 21144955
17. MB Mainiero CM Cinelli SL Koelliker, et al. 2010 Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance AJR Am J Roentgenol 195 1261 1267 20966338
18. N Cho WK Moon W Han, et al. 2009 Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results AJR Am J Roentgenol 193 1731 1737 19933672
19. I Steppan D Reimer E Muller-Holzner, et al. 2010 Breast cancer in women: evaluation of benign and malignant axillary lymph nodes with contrast-enhanced ultrasound Ultraschall Med 31 63 67 20094979 1:STN:280:DC%2BC3c7js1WltQ%3D%3D
20. JS Sloka PD Hollett M Mathews 2007 A quantitative review of the use of FDG-PET in the axillary staging of breast cancer Med Sci Monit 13 RA37 RA46 17325645
21. R Peare RT Staff SD Heys 2010 The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature Breast Cancer Res Treat 123 281 290 20140703
22. ME Straver TS Aukema RA Olmos, et al. 2010 Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients Eur J Nucl Med Mol Imaging 37 1069 1076 20130860
23. JH Ahn EJ Son JA Kim, et al. 2010 The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer Acta Radiol 51 859 865 20670083
24. T Harada N Tanigawa M Matsuki, et al. 2007 Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging Eur J Radiol 63 401 407 17398053 (Pubitemid 47321038)
25. TW Stadnik H Everaert S Makkat, et al. 2006 Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging for axillary lymph node staging-initial findings Eur Radiol 16 2153 2160 16670863 (Pubitemid 44354549)
26. AD Murray RT Staff TW Redpath, et al. 2002 Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes Br J Radiol 75 220 228 11932214 1:STN:280:DC%2BD387pvFWktw%3D%3D (Pubitemid 34436274)
27. SC Michel TM Keller JM Frohlich, et al. 2002 Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement Radiology 225 527 536 12409591 (Pubitemid 35239258)
28. M Memarsadeghi CC Riedl A Kaneider, et al. 2006 Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging Radiology 241 367 377 17057065 (Pubitemid 44632881)
29. T Suzuma T Sakurai G Yoshimura, et al. 2002 MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection Breast Cancer 9 69 74 12196725
30. C Stets S Brandt F Wallis, et al. 2002 Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO J Magn Reson Imaging 16 60 68 12112504 (Pubitemid 34700843)
31. K Kitagawa H Sakuma N Ishida, et al. 2004 Contrast-enhanced high-resolution MRI of invasive breast cancer: correlation with histopathologic subtypes AJR Am J Roentgenol 183 1805 1809 15547233 (Pubitemid 44210562)
32. TF Bathen LR Jensen B Sitter, et al. 2007 MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status Breast Cancer Res Treat 104 181 189 17061040 (Pubitemid 47086272)
33. KA Gelmon 2010 The ongoing debate about nodes Clin Breast Cancer 10 265 266 20705557
34. P Tai E Yu K Joseph 2010 Prognostic significance of number of positive nodes: a long-term study of one to two nodes versus three nodes in breast cancer patients Int J Radiat Oncol Biol Phys 77 180 187 20394852
35. HA Hatoum FR Jamali NS El Saghir, et al. 2009 Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer Ann Surg Oncol 16 3388 3395 19655200
36. SJ Crabb MC Cheang S Leung, et al. 2008 Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer Clin Breast Cancer 8 249 256 18650155 (Pubitemid 351962146)
37. B Van Calster I Vanden Bempt M Drijkoningen, et al. 2009 Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive Breast Cancer Res Treat 113 181 187 18264760
38. H Wildiers B Van Calster LV van de Poll-Franse, et al. 2009 Relationship between age and axillary lymph node involvement in women with breast cancer J Clin Oncol 27 2931 2937 19451448
39. E Botteri V Bagnardi A Goldhirsch, et al. 2010 Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer 10 318 321 20705566
40. H Kennecke R Yerushalmi R Woods, et al. 2010 Metastatic behavior of breast cancer subtypes J Clin Oncol 28 3271 3277 20498394
41. KD Voduc MC Cheang S Tyldesley, et al. 2010 Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 1684 1691 20194857
42. WD Foulkes MJ Grainge EA Rakha, et al. 2009 Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status Breast Cancer Res Treat 117 199 204 18600446
43. FM Blows KE Driver MK Schmidt, et al. 2010 Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10, 159 cases from 12 studies PLoS Med 7 e1000279 20520800
44. KE Huber LA Carey DE Wazer 2009 Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy Semin Radiat Oncol 19 204 210 19732684
45. MJ van de Vijver YD He LJ van't Veer, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009 12490681 (Pubitemid 35461656)
46. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869 10874 11553815 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
47. T Reimer R Fietkau S Markmann, et al. 2008 How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis Ann Surg Oncol 15 472 477 17987339
48. M Martin MA Segui A Anton, et al. 2010 Adjuvant docetaxel for high-risk, node-negative breast cancer N Engl J Med 363 2200 2210 21121833 1:CAS:528:DC%2BC3cXhsFWqsb7N
49. M Untch RD Gelber C Jackisch, et al. 2008 Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial Ann Oncol 19 1090 1096 18296421 1:STN:280:DC%2BD1czktlSlsA%3D%3D (Pubitemid 351796334)
50. J Engel A Lebeau H Sauer, et al. 2006 Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection Breast 15 452 455 16054813 1:STN:280:DC%2BD28vkslymtw%3D%3D
51. HG Moon W Han DY Noh 2010 Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society J Clin Oncol 28 1692 1699 20194848
52. MR Kell JP Burke M Barry, et al. 2010 Outcome of axillary staging in early breast cancer: a meta-analysis Breast Cancer Res Treat 120 441 447 20063121
53. SR Land JA Kopec TB Julian, et al. 2010 Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32 J Clin Oncol 28 3929 3936 20679600
54. CM Rudenstam D Zahrieh JF Forbes, et al. 2006 Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93 J Clin Oncol 24 337 344 16344321 (Pubitemid 46630451)
55. G Martelli P Boracchi M De Palo, et al. 2005 A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up Ann Surg 242 1 6 15973094 (Pubitemid 40917960)
56. U Veronesi R Orecchia S Zurrida, et al. 2005 Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy Ann Oncol 16 383 388 15668261 1:STN:280:DC%2BD2M%2FptVGksw%3D%3D (Pubitemid 40458313)
57. G Martelli R Miceli MG Daidone, et al. 2011 Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up Ann Surg Oncol 18 125 133 20652755
58. I Fredriksson G Liljegren LG Arnesson, et al. 2002 Consequences of axillary recurrence after conservative breast surgery Br J Surg 89 902 908 12081741 1:STN:280:DC%2BD38zosFyjtA%3D%3D (Pubitemid 34779576)
59. C Louis-Sylvestre K Clough B Asselain, et al. 2004 Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up J Clin Oncol 22 97 101 14701770 (Pubitemid 41095119)
60. R Bourez E Rutgers C van De Velde 2002 Will we need lymph node dissection at all in the future? Clin Breast Cancer 3 315 322 12533260 (Pubitemid 36124467)
61. ME Straver P Meijnen G van Tienhoven, et al. 2010 Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial Ann Surg Oncol 17 1854 1861 20300966
62. SB Evans J Gass DE Wazer 2008 Management of the axilla after the finding of a positive sentinel lymph node: a proposal for an evidence-based risk-adapted algorithm Am J Clin Oncol 31 293 299 18525310
63. DN Krag SJ Anderson TB Julian, et al. 2007 Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881 888 17851130 1:CAS:528:DC%2BD2sXhtFektbzM (Pubitemid 47488052)
64. G Canavese A Catturich C Vecchio, et al. 1998 Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer Eur J Surg Oncol 24 104 109 9591024 1:STN:280:DyaK1c3ltlanuw%3D%3D (Pubitemid 28205937)
65. KM Erb TB Julian 2009 Completion of axillary dissection for a positive sentinel node: necessary or not? Curr Oncol Rep 11 15 20 19080737
66. JY Wo AG Taghian PL Nguyen, et al. 2010 The association between biological subtype and isolated regional nodal failure after breast-conserving therapy Int J Radiat Oncol Biol Phys 77 188 196 20171798
67. IL Wapnir SJ Anderson EP Mamounas, et al. 2006 Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials J Clin Oncol 24 2028 2037 16648502 (Pubitemid 46622111)
68. AE Giuliano L McCall P Beitsch, et al. 2010 Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 426 432 20739842
69. AE Giuliano KK Hunt KV Ballman, et al. 2011 Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis JAMA 305 569 575 21304082 1:CAS:528:DC%2BC3MXhvVymtrg%3D
70. M Yi SH Giordano F Meric-Bernstam, et al. 2010 Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database Ann Surg Oncol 17 S343 S351
71. KY Bilimoria DJ Bentrem NM Hansen, et al. 2009 Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2946 2953 19364968
72. U Veronesi E Marubini L Mariani, et al. 1999 The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial Eur J Cancer 35 1320 1325 10658521 1:STN:280:DC%2BD3c7it12qsw%3D%3D (Pubitemid 29397430)
73. W Janni B Rack H Sommer, et al. 2003 Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases J Cancer Res Clin Oncol 129 503 510 12884027 (Pubitemid 37211191)
74. PS Sinha S Thrush S Bendall, et al. 2002 Does radical surgery to the axilla give a survival advantage in more severe breast cancer? Eur J Cancer 38 1474 1477 12110493 1:STN:280:DC%2BD38zms1Clsw%3D%3D (Pubitemid 34756400)
75. KJ Van Zee DM Manasseh JL Bevilacqua, et al. 2003 A nomogram for predicting the likelihood in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 14654469 (Pubitemid 40486808)
76. JL Bevilacqua MW Kattan JV Fey, et al. 2007 Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol 25 3670 3679 17664461 (Pubitemid 47372606)
77. MC Specht MW Kattan J Fey, et al. 2005 Predicting nonsentinel node status after positive sentinel lymph node biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 12 654 659 16021535 (Pubitemid 41126095)
78. S Alran Y De Rycke V Fourchotte, et al. 2007 Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 14 2195 2201 17294071 (Pubitemid 47174905)
79. G Cserni D Gregori F Merletti, et al. 2004 Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 1245 1252 15376203 1:STN:280:DC%2BD2cvpsFehtQ%3D%3D (Pubitemid 39331448)
80. I Langer U Guller CT Viehl, et al. 2009 Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study Ann Surg Oncol 16 3366 3374 19760047
81. AA Sahin M Guray KK Hunt 2009 Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer Arch Pathol Lab Med 133 869 878 19492879
82. G Cserni I Amendoeira N Apostolikas, et al. 2003 Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines Eur J Cancer 39 1654 1667 12888359 1:STN:280:DC%2BD3szlsFCnsg%3D%3D (Pubitemid 36897601)
83. RR Turner DL Weaver G Cserni, et al. 2008 Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training J Clin Oncol 26 258 263 18182666
84. N Klauber-DeMore KJ Van Zee I Linkov, et al. 2001 Biological behavior of human breast cancer micrometastases Clin Cancer Res 7 2434 2439 11489823 1:STN:280:DC%2BD3MvktlehtA%3D%3D (Pubitemid 32751646)
85. I de Mascarel G MacGrogan M Debled, et al. 2008 Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful? Cancer 112 1672 1678 18286534 (Pubitemid 351551810)
86. LK Tan D Giri AJ Hummer, et al. 2008 Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 1803 1809 18332473
87. S Yegiyants LM Romero PI Haigh, et al. 2010 Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node Arch Surg 145 564 569 20566977
88. B Gerber A Krause H Muller, et al. 2001 Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors J Clin Oncol 19 960 971 11181658 1:STN:280:DC%2BD3M3gsFamug%3D%3D (Pubitemid 32176270)
89. M de Boer CH van Deurzen JA van Dijck, et al. 2009 Micrometastases or isolated tumor cells and the outcome of breast cancer N Engl J Med 361 653 663 19675329
90. PJ van Diest M de Boer CH van Deurzen, et al. 2010 Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome J Clin Oncol 28 e140 e142 20159803
91. NM Hansen B Grube X Ye, et al. 2009 Impact of micrometastases in the sentinel node of patients with invasive breast cancer J Clin Oncol 27 4679 4684 19720928
92. J Reed M Rosman KM Verbanac, et al. 2009 Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study J Am Coll Surg 208 333 340 19317993
93. I van der Ploeg OE Nieweg MC van Rijk, et al. 2008 Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature Eur J Surg Oncol 34 1277 1284 18406100
94. G Masci L Di Tommaso I Del Prato, et al. 2010 Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer Ann Oncol 21 1228 1232 19875751 1:STN:280:DC%2BC3czlvF2qtQ%3D%3D
95. M de Boer JA van Dijck P Bult, et al. 2010 Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases J Natl Cancer Inst 102 410 425 20190185
96. DL Weaver T Ashikaga DN Krag, et al. 2011 Effect of occult metastases on survival in node-negative breast cancer N Engl J Med 364 412 421 21247310 1:CAS:528:DC%2BC3MXhsFGhsL0%3D
97. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al (2010) Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat. doi: 10.1007/s10549-010-1086-6
98. E Montagna G Viale N Rotmensz, et al. 2009 Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure Breast Cancer Res Treat 118 385 394 19562480 1:STN:280:DC%2BD1Mnps1ekug%3D%3D
99. PD Gobardhan SG Elias EV Madsen, et al. 2009 Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study Ann Oncol 20 41 48 18653702 1:STN:280:DC%2BD1M%2Fns1ymsw%3D%3D
100. CE Cox JV Kiluk AI Riker, et al. 2008 Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 261 268 18222378
101. T Nagashima M Sakakibara S Nakano, et al. 2006 Sentinel node micrometastasis and distant failure in breast cancer patients Breast Cancer 13 186 191 16755115
102. S Imoto A Ochiai C Okumura, et al. 2006 Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining Eur J Surg Oncol 32 1175 1179 16979316 1:STN:280:DC%2BD28novVCjsQ%3D%3D (Pubitemid 44774413)
103. YG Fan YY Tan CT Wu, et al. 2005 The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer Ann Surg Oncol 12 705 711 16079953
104. A Cyr WE Gillanders RL Aft, et al. 2010 Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden Ann Surg Oncol 17 S303 S311
105. CR Tait D Dodwell K Horgan 2004 Do metastases metastasize? J Pathol 203 515 518 15095473 (Pubitemid 38529030)
106. R Bernards RA Weinberg 2002 A progression puzzle Nature 418 823 12192390 1:CAS:528:DC%2BD38XmtlWlsLw%3D (Pubitemid 34966286)
107. X Lu CH Yan M Yuan, et al. 2010 In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer Cancer Res 70 3905 3914 20442288 1:CAS:528:DC%2BC3cXlvFyrtb8%3D
108. X Lu Y Kang 2007 Organotropism of breast cancer metastasis J Mammary Gland Biol Neoplasia 12 153 162 17566854 (Pubitemid 47215433)
109. M Smid Y Wang Y Zhang, et al. 2008 Subtypes of breast cancer show preferential site of relapse Cancer Res 68 3108 3114 18451135 1:CAS:528:DC%2BD1cXltlSmt7Y%3D
110. S Ran L Volk K Hall, et al. 2010 Lymphangiogenesis and lymphatic metastasis in breast cancer Pathophysiology 17 229 251 20036110
111. B Fisher ER Fisher 1966 Transmigration of lymph nodes by tumor cells Science 152 1397 1398 5949244 1:STN:280:DyaF287ktFOjug%3D%3D
112. J Krishnan V Kirkin A Steffen, et al. 2003 Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats Cancer Res 63 713 722 12566318 1:CAS:528:DC%2BD3sXosVyhsQ%3D%3D (Pubitemid 36158152)
113. S Hirakawa LF Brown S Kodama, et al. 2007 VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites Blood 109 1010 1017 17032920 1:CAS:528:DC%2BD2sXjtFertrs%3D (Pubitemid 46220646)
114. RA Mohammed A Green S El Shikh, et al. 2007 Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis Br J Cancer 96 1092 1100 17353919 1:CAS:528:DC%2BD2sXjsleksLc%3D (Pubitemid 46608319)
115. Y Nakamura H Yasuoka M Tsujimoto, et al. 2005 Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer Breast Cancer Res Treat 91 125 132 15868440 1:CAS:528:DC%2BD2MXjvVWjsr4%3D (Pubitemid 40684925)
116. H Yasuoka M Tsujimoto K Yoshidome, et al. 2008 Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis BMC Cancer 8 340 19025611
117. N Cabioglu MS Yazici B Arun, et al. 2005 CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer Clin Cancer Res 11 5686 5693 16115904 1:CAS:528:DC%2BD2MXos1CjsL4%3D (Pubitemid 41170291)
118. SJ Aitken JS Thomas SP Langdon, et al. 2010 Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases Ann Oncol 21 1254 1261 19858088 1:STN:280:DC%2BC3czlvF2ktQ%3D%3D
119. IJ Fidler 2003 The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat Rev Cancer 3 453 458 12778135 1:CAS:528: DC%2BD3sXktFOnsbg%3D (Pubitemid 37328849)
120. SY Wong RO Hynes 2006 Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5 812 817 16627996 1:CAS:528:DC%2BD28XmvVGrurk%3D (Pubitemid 44149486)
121. K Pantel RJ Cote O Fodstad 1999 Detection and clinical importance of micrometastatic disease J Natl Cancer Inst 91 1113 1124 10393719 1:STN:280:DyaK1Mzit1Sisw%3D%3D (Pubitemid 29330549)
122. G Wiedswang E Borgen C Schirmer, et al. 2006 Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer Int J Cancer 118 2013 2019 16287086 1:CAS:528:DC%2BD28Xjt1GqurY%3D
123. FC Bidard C Mathiot S Delaloge, et al. 2010 Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer Ann Oncol 21 729 733 19850639
124. FC Bidard A Vincent-Salomon B Sigal-Zafrani, et al. 2008 Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells Ann Oncol 19 496 500 18187488 (Pubitemid 351325670)
125. O Schmidt-Kittler T Ragg A Daskalakis, et al. 2003 From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 7737 7742 12808139 1:CAS:528:DC%2BD3sXlt1Wqs7s%3D (Pubitemid 36760039)
126. JA Schardt M Meyer CH Hartmann, et al. 2005 Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer Cancer Cell 8 227 239 16169467 1:CAS:528:DC%2BD2MXhtV2gt7vN (Pubitemid 41317593)
127. PA Theodoropoulos H Polioudaki S Agelaki, et al. 2010 Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer Cancer Lett 288 99 106 19619935 1:CAS:528:DC%2BC3cXnvFyltA%3D%3D
128. S Liu MS Wicha 2010 Targeting breast cancer stem cells J Clin Oncol 28 4006 4012 20498387 1:CAS:528:DC%2BC3cXht1eqsb3K
129. McDermott SP, Wicha MS (2010) Targeting breast cancer stem cells. Mol Oncol 4(5):404-419
130. M Kakarala MS Wicha 2008 Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy J Clin Oncol 26 2813 2820 18539959